Kaveh Tabrizian

Kaveh Tabrizian

Auto-generated profile, based on publicly available information

Kaveh Tabrizian

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Oncology Reports
Verified
Journal Article
Open access
PDF file
MHMahmoud Hashemzaei
Mahmoud Hashemzaei
AFAmin Delarami Far
Amin Delarami Far
AYArezoo Yari
Arezoo Yari
RHReza Entezari Heravi
Reza Entezari Heravi
KTKaveh Tabrizian
Kaveh Tabrizian
RRRamin Rezaee
Ramin Rezaee
The present study focused on the elucidation of the putative anticancer potential of quercetin. The anticancer activity of quercetin at 10, 20, 40, 80 and 120 µM was assessed in vitro by MMT assay in 9 tumor cell lines (colon carcinoma CT‑26 cells, prostate adenocarcinoma LNCaP cells, human prostate PC3 cells, pheocromocytoma PC12 cells, estrogen receptor‑positive breast cancer MCF‑7 cells, acute lymphoblastic leukemia MOLT‑4 T‑cells, human myeloma U266B1 cells, human lymphoid Raji cells and ovarian cancer CHO cells). Quercetin was found to induce the apoptosis of all the tested cancer cell lines at the utilized concentrations. Moreover, quercetin significantly induced the apoptosis of the CT‑26, LNCaP, MOLT‑4 and Raji cell lines, as compared to control group (P<0.001), as demonstrated by Annexin V/PI staining. In in vivo experiments, mice bearing MCF‑7 and CT‑26 tumors exhibited a significant reduction in tumor volume in the quercetin‑treated group as compared to the control group (P<0.001). Taken together, quercetin, a naturally occurring compound, exhibits anticancer properties both in vivo and in vitro.

14 January 2021 in BMC Medical Education
Verified
Journal Article
Open access
PDF file
MHMahmoud Hashemzaei
Mahmoud Hashemzaei
MAMahdi Afshari
Mahdi Afshari
ZKZahra Koohkan
Zahra Koohkan
ABAli Bazi
Ali Bazi
RRRamin Rezaee
Ramin Rezaee
KTKaveh Tabrizian
Kaveh Tabrizian
Background: Self-medication is defined as using medicinal products to treat the disorders or symptoms diagnosed by oneself. Although informed self-medication is one of the ways to reduce health care costs, inappropriate self-treatment can pose various risks including drug side effects, recurrence of symptoms, drug resistance, etc. The purpose of this study was to investigate the knowledge, attitude, and practice of pharmacy and medical students toward self-medication. Methods: This study was conducted in Zabol University of Medical Sciences in 2018. Overall, 170 pharmacy and medical students were included. A three-part researcher-made questionnaire was designed to address the students’ knowledge, attitude, and practice. Statistical analysis was performed in SPSS 25 software. Results: According to the results, 97 (57.1%) students had carried out self-medication within the past 6 months. Overall, the students self-medicated on average 4.2 ± 2.9 times per year. Self-medication was more common in male students (65.4%, P = 0.043). Cold was the most common ailment treated with self-medication (93.2%), and antibiotics (74.4%) were the most commonly used drugs. The primary information sources used by the students were their previous prescriptions (47.4%). Pharmacy students had a higher level of drug information (P < 0.001). There was a statistically significant association between the level of drug information and the tendency for self-medication (P = 0.005). Disease recurrence was the most common negative complication of self-medication. Conclusion: There is a need to educate pharmacy and medical students regarding self-medication and its side effects. The high prevalence of self-medication and the overuse of antibiotics can pose a significant risk of drug resistance.

13 January 2015 in Human & Experimental Toxicology
Verified
Journal Article
Closed access
PDF file
VMV Mashayekhi
V Mashayekhi
KTKamaleddin Haj Mohammad Ebrahim Tehrani
Kamaleddin Haj Mohammad Ebrahim Tehrani
MHM Hashemzaei
M Hashemzaei
KTK Tabrizian
K Tabrizian
JSJ Shahraki
J Shahraki
MHMir-Jamal Hosseini
Mir-Jamal Hosseini
Background: Perfluorooctanoic acid (PFOA) is one of the most widely used perfluoroalkanes as surfactants, lubricants and processing aids in the production of polymers, which has also been detected in the environment, wildlife and human body. Animal studies indicated that PFOA caused a wide array of toxic effects including liver and brain dysfunction, carcinogenicity and reproductive and developmental toxicity. Based on the established role of mitochondria-mediated pathways in the observed toxic effects of many drugs and chemicals, in this study, the potential toxic effects of PFOA on mitochondria isolated from rat liver and brain have been investigated. Method: Mitochondria were isolated by differential centrifugation method and incubated with different concentrations of PFOA (0.5–1.5 mM). The effects of PFOA were assessed on a series of mitochondrial parameters including reactive oxygen species (ROS) formation, activities of mitochondrial complexes I/II/III, reduced glutathione (GSH) content, adenosine triphosphate (ATP) level, membrane potential, lipid peroxidation (LPO), mitochondrial swelling and cytochrome c release. Results: The data on liver mitochondria indicated that PFOA-induced ROS elevation in both mitochondrial complexes I and III, mitochondrial membrane potential collapse, swelling, cytochrome c release and decreased ATP level which induces apoptosis or necrosis. On brain mitochondria, PFOA showed fairly similar effects on the above-mentioned parameters. However, different results were obtained when the effect of PFOA was assessed on LPO and complex II activity. Conclusions: Due to the fact that PFOA had toxic effects on the mitochondria isolated, it could be suggested that mitochondrial toxicity could be a plausible mechanism for the toxic effects of this fluorochemical on liver and brain function.

1 May 2014 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
STSeyed Mohammad Taghdisi
Seyed Mohammad Taghdisi
SESomayeh Sarreshtehdar Emrani
Somayeh Sarreshtehdar Emrani
KTKaveh Tabrizian
Kaveh Tabrizian
MRMohammad Ramezani
Mohammad Ramezani
KAKhalil Abnous
Khalil Abnous
AEAhmad Sarreshtehdar Emrani
Ahmad Sarreshtehdar Emrani

1 January 2012 in Behavioural Brain Research
Verified
Journal Article
Closed access
BEBahareh Eftekharzadeh
Bahareh Eftekharzadeh
MRMahmoudreza Ramin
Mahmoudreza Ramin
FKFariba Khodagholi
Fariba Khodagholi
SMShahla Moradi
Shahla Moradi
KTKaveh Tabrizian
Kaveh Tabrizian
MSMohammad Sharifzadeh
Mohammad Sharifzadeh

1 September 2016 in Environmental Toxicology and Pharmacology
Verified
Journal Article
Closed access
MHMahmoud Hashemzaei
Mahmoud Hashemzaei
ABArian Khandan Barani
Arian Khandan Barani
MIMehrdad Iranshahi
Mehrdad Iranshahi
RRRamin Rezaee
Ramin Rezaee
KTKonstantinos Tsarouhas
Konstantinos Tsarouhas
KTKaveh Tabrizian
Kaveh Tabrizian